Concepedia

Shintaro Taki

ST

Statistics

Publications

8

Citations

216

H-Index

8

Active since

2010

Affiliations

Tohoku University(Current)

National Institute of Biomedical Innovation, Health and Nutrition

The University of Osaka

Shintaro Taki is an author at Tohoku University specializing in cd3-directed bispecific antibodies, bispecific antibodies, and immunology.

Publications per year

2010–2017

8

Publications

8

A Novel Bispecific Antibody against Human CD3 and Ephrin Receptor A10 for Breast Cancer Therapy

Shintaro Taki, Haruhiko Kamada, Masaki Inoue et al. · PLoS ONE · 2015 · 44 citations · Full text

, , +17

Domain order of a bispecific diabody dramatically enhances its antitumor activity beyond structural format conversion: the case of the hEx3 diabody

Ryutaro Asano, Takashi Kumagai, Keisuke Nagai et al. · Protein Engineering Design and Selection · 2013 · 40 citations

, , +17

Cytotoxic Enhancement of a Bispecific Diabody by Format Conversion to Tandem Single-chain Variable Fragment (taFv)

Ryutaro Asano, Ippei Shimomura, Shintaro Taki et al. · Journal of Biological Chemistry · 2010 · 28 citations · Full text

, , +17

Highly Enhanced Cytotoxicity of a Dimeric Bispecific Diabody, the hEx3 Tetrabody

Ryutaro Asano, Yukiko Sone, Hiroko Kawaguchi et al. · Journal of Biological Chemistry · 2010 · 28 citations · Full text

, , +17

Rearranging the domain order of a diabody-based IgG-like bispecific antibody enhances its antitumor activity and improves its degradation resistance and pharmacokinetics

Ryutaro Asano, Ippei Shimomura, S. KONNO et al. · mAbs · 2014 · 25 citations · Full text

, , +17

1–5 of 8